Physician profile
Ruth Devadas
NPI 1548556186
$3,029.12
in general payments reported to CMS, 2019-2025
12 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.49 · 2020: $19.00 · 2022: $2,471 · 2023: $177 · 2024: $34.18 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $2,513.04 | 2022-2025 | |
| Stryker Corporation | $134.38 | 2023-2025 | Inbone, Anchorage |
| Medtronic, INC. | $83.42 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Progenacare Global, LLC | $82.04 | 2023 | |
| Organogenesis INC. | $69.10 | 2019-2025 | Simplimax |
| Paratek Pharmaceuticals, INC. | $31.66 | 2025 | Nuzyra |
| Native Surgical, LLC | $28.03 | 2025 | |
| Smith+Nephew, INC. | $25.58 | 2025 | Grafix Pl, Stravix Pl |
| Tactile Systems Technology INC | $25.44 | 2025 | Nimbl, Flexitouch Plus |
| Kerecis Limited | $14.84 | 2022 | |
| Merck Sharp & Dohme LLC | $10.88 | 2019 | |
| Arthrosurface Incorporated | $10.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Devadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.